Latest news with #AGM2025
Time of India
3 days ago
- Business
- Time of India
India soars to 3rd spot in global aviation market, says IATA
India's aviation sector has surpassed pre-pandemic levels and now ranks as the third-largest aviation market in the world in terms of passenger traffic , according to the International Air Transport Association (IATA). However, the global airline body has flagged rising costs and tax-related uncertainty as critical challenges for the industry. 'It (India) is now the third largest aviation market in the world in terms of passenger traffic, which includes both India's domestic as well as international traffic. It is also the sixth largest market for air cargo, and overall, a very exciting aviation market like I mentioned, which is on account of the emergence of stronger airlines which are growing its connections both within and outside of India,' said Amitabh Khosla, Country Director – India, IATA, speaking on Sunday at the IATA AGM 2025 in Delhi. According to IATA's report, as of December 2024, the international sector is almost 20% above its 2019 level, while domestic is more than 8% higher. 'Such a positive recovery reaffirms the strong demand within India for both domestic and international air travel and provides a firm foundation for the period ahead.' However, it cautioned that the positive outlook does not come without its challenges – for the airlines, its industry partners and policymakers alike – to ensure that this growth potential can be met, and the available benefits of aviation accrue fully to the country and its citizens. Live Events 'Airline profitability is not guaranteed, and the wider regulatory environment must support sustainable air transport growth within the country. In particular, conversations regarding infrastructure development, taxation, labor and skills challenges, and ensuring climate change and sustainability considerations are addressed, are all required to secure a positive future for the industry and, in turn, the country.' Khosla added that the body hoped that the issue of the high cost environment for aviation in India that could be addressed, especially for taxation, where in general, there is a higher degree of uncertainty for tax planning that funds have to bear in mind there continue to be various issues around GST that still need clarification. 'There are positions that are taken by the tax authorities in India, or frequent tax notices on untested and new issues, for example, in 2023–24 you would recall there was this earlier contrary position taken about GST on import of services between airline headquarters and their branch offices in India, which to great credit to the tax authorities has finally been addressed in line with international principles. But in more recent months, end of 24 and beginning of 25 there is this other instance of notices being issued to some aircraft leasing companies where there is an expected cost impact which will have to be borne by the Indian carriers,' Khosla said.
Yahoo
6 days ago
- Business
- Yahoo
New number of shares and votes in Telefonaktiebolaget LM Ericsson
STOCKHOLM, May 30, 2025 /PRNewswire/ -- The total number of shares in Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) as of May 30, 2025, amounts to 3,371,351,735 of which 261,755,983 are A shares and 3,109,595,752 are B shares. The total number of votes is 572,715,558.2 of which the A shares represent 261,755,983 votes and the B shares represent 310,959,575.2 votes. The increase in the number of shares and votes is a result of the company's issue of a total of 23.1 million C shares completed in May 2025. The C shares have subsequently been repurchased by the company and converted into B shares by virtue of a conversion clause in the articles of association. This is in accordance with the resolution by the AGM 2025 to expand the treasury stock as part of the financing of the Long-Term Variable Compensation Programs LTV 2025 and LTV 2024 for the company's executive team and other executives. The company currently holds 38,065,074 B shares as treasury stock. This information is information that Telefonaktiebolaget LM Ericsson is obliged to make public pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication at 08.00 CEST on May 30, 2025. NOTES TO EDITORS: FOLLOW US: Subscribe to Ericsson press releasesSubscribe to Ericsson blog postshttps:// MORE INFORMATION AT:Ericsson (+46 10 719 69 92) (+46 10 719 00 00) ABOUT ERICSSON: Ericsson's high-performing networks provide connectivity for billions of people every day. For nearly 150 years, we've been pioneers in creating technology for communication. We offer mobile communication and connectivity solutions for service providers and enterprises. Together with our customers and partners, we make the digital world of tomorrow a reality. This information was brought to you by Cision The following files are available for download: New number of shares and votes in Telefonaktiebolaget LM Ericsson View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21-05-2025
- Business
- Yahoo
Cellectis' Annual Shareholders General Meeting to be Held on June 26, 2025
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Cellectis (the 'Company') (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will hold its annual general meeting on June 26, 2025 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France. The notice convening the annual general meeting stating the detailed agenda and modalities of participation in the meeting and the report of the board of directors to the shareholders meeting are available on the Cellectis website: About Cellectis Cellectis is a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies. The company utilizes an allogeneic approach for CAR T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients, and a platform to develop gene therapies in other therapeutic indications. With its in-house manufacturing capabilities, Cellectis is one of the few end-to-end gene editing companies that controls the cell and gene therapy value chain from start to finish. Cellectis' headquarters are in Paris, France, with locations in New York and Raleigh, NC. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find out more, visit and follow Cellectis on LinkedIn and X. For further information on Cellectis, please contact: Media contacts: Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@ Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93 Investor Relations contact: Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@ 20240521_AGM 2025 announcement_ENGLISHSign in to access your portfolio
Yahoo
08-05-2025
- Business
- Yahoo
Philips shareholders approve all proposals at the AGM 2025
Philips AGM 2025 Chairman Feike Sijbesma and a member of the Board of Management Marnix van Ginneken during Philips AGM 2025 May 8, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2025, including: The re-appointment of Ms Indra Nooyi and Ms Chua Sock Koong as members of the Supervisory Board. The appointment of Mr Bob White as a new member of the Supervisory Board. The re-appointment of Mr Marnix van Ginneken as member of the Board of Management. The discharge of the members of the Board of Management, and of the members of the Supervisory Board. A full overview of the resolutions taken at the AGM 2025 can be found below. Feike Sijbesma, Chairman of Philips' Supervisory Board, said: 'On behalf of the Supervisory Board and the Board of Management, I extend our heartfelt thanks to David Pyott for his invaluable counsel over the past decade. We are also delighted to welcome Bob White to the Supervisory Board and are very pleased with the re-appointment of Indra Nooyi and Chua Sock Koong. With our highly knowledgeable and experienced members, our Supervisory Board is well-equipped to advise and support Management as they execute Philips' strategy.' Mr Sijbesma added: 'Together with my colleagues on the Supervisory Board, we extend our congratulations to Marnix van Ginneken on his re-appointment as a member of Philips' Board of Management. With his strong leadership, profound understanding of the company, and his extensive international corporate governance experience, he is a tremendous asset to Philips.' Roy Jakobs, CEO of Royal Philips, said: 'I am very pleased with Bob White's appointment to our Supervisory Board. He is a recognized global business leader with deep expertise in health technology. Philips has benefited greatly from the expertise and contributions of Indra Nooyi and Chua Sock Koong, and we are very happy with their re-appointment. Our CFO Charlotte Hanneman and I look forward to continued successful collaboration with Marnix van Ginneken who has been instrumental to Philips, as we strive to improve health and well-being of people through meaningful innovation.' All resolutions taken at the AGM 2025: Agenda item Resolution 3 Annual Report 2024 Adoption of the financial statements 2024 Adoption of a dividend of EUR 0.85 per common share, in shares or (subject to certain conditions) in cash, against retained earnings Positive advisory vote on the approval of the Remuneration Report 2024 Discharge of the members of the Board of Management Discharge of the members of the Supervisory Board 4 Composition of the Board of Management Appointment of Mr Van Ginneken as member of the Board of Management with effect from May 8, 2025 5 Composition of the Supervisory Board Re-appointment of Ms Chua as member of the Supervisory Board with effect from May 8, 2025 Re-appointment of Ms Nooyi as member of the Supervisory Board with effect from May 8, 2025 Appointment of Mr White as member of the Supervisory Board with effect from May 8, 2025 6 Authorization of the Board of Management to issue shares or grant rights to acquire shares and restrict or exclude pre-emption rights 7 Authorization of the Board of Management to acquire shares in the company 8 Cancellation of shares Further details about the dividend can be found via this link, and additional information on the composition of the Board of Management, the Executive Committee and the Supervisory Board can be found here. Philips' 2024 financial statements are included in its Annual Report 2024 that was published on February 21, more information about Philips' AGM 2025, please click on this link. For further information, please contact: Michael FuchsPhilips Global External RelationsTel.: +31 614869261E-mail: media@ Dorin DanuPhilips Investor RelationsTel.: +31 20 59 77055E-mail: About Royal PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at Attachments Philips AGM 2025 Chairman Feike Sijbesma and a member of the Board of Management Marnix van Ginneken during Philips AGM 2025Sign in to access your portfolio
Yahoo
08-05-2025
- Business
- Yahoo
Philips shareholders approve all proposals at the AGM 2025
Philips AGM 2025 Chairman Feike Sijbesma and a member of the Board of Management Marnix van Ginneken during Philips AGM 2025 May 8, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2025, including: The re-appointment of Ms Indra Nooyi and Ms Chua Sock Koong as members of the Supervisory Board. The appointment of Mr Bob White as a new member of the Supervisory Board. The re-appointment of Mr Marnix van Ginneken as member of the Board of Management. The discharge of the members of the Board of Management, and of the members of the Supervisory Board. A full overview of the resolutions taken at the AGM 2025 can be found below. Feike Sijbesma, Chairman of Philips' Supervisory Board, said: 'On behalf of the Supervisory Board and the Board of Management, I extend our heartfelt thanks to David Pyott for his invaluable counsel over the past decade. We are also delighted to welcome Bob White to the Supervisory Board and are very pleased with the re-appointment of Indra Nooyi and Chua Sock Koong. With our highly knowledgeable and experienced members, our Supervisory Board is well-equipped to advise and support Management as they execute Philips' strategy.' Mr Sijbesma added: 'Together with my colleagues on the Supervisory Board, we extend our congratulations to Marnix van Ginneken on his re-appointment as a member of Philips' Board of Management. With his strong leadership, profound understanding of the company, and his extensive international corporate governance experience, he is a tremendous asset to Philips.' Roy Jakobs, CEO of Royal Philips, said: 'I am very pleased with Bob White's appointment to our Supervisory Board. He is a recognized global business leader with deep expertise in health technology. Philips has benefited greatly from the expertise and contributions of Indra Nooyi and Chua Sock Koong, and we are very happy with their re-appointment. Our CFO Charlotte Hanneman and I look forward to continued successful collaboration with Marnix van Ginneken who has been instrumental to Philips, as we strive to improve health and well-being of people through meaningful innovation.' All resolutions taken at the AGM 2025: Agenda item Resolution 3 Annual Report 2024 Adoption of the financial statements 2024 Adoption of a dividend of EUR 0.85 per common share, in shares or (subject to certain conditions) in cash, against retained earnings Positive advisory vote on the approval of the Remuneration Report 2024 Discharge of the members of the Board of Management Discharge of the members of the Supervisory Board 4 Composition of the Board of Management Appointment of Mr Van Ginneken as member of the Board of Management with effect from May 8, 2025 5 Composition of the Supervisory Board Re-appointment of Ms Chua as member of the Supervisory Board with effect from May 8, 2025 Re-appointment of Ms Nooyi as member of the Supervisory Board with effect from May 8, 2025 Appointment of Mr White as member of the Supervisory Board with effect from May 8, 2025 6 Authorization of the Board of Management to issue shares or grant rights to acquire shares and restrict or exclude pre-emption rights 7 Authorization of the Board of Management to acquire shares in the company 8 Cancellation of shares Further details about the dividend can be found via this link, and additional information on the composition of the Board of Management, the Executive Committee and the Supervisory Board can be found here. Philips' 2024 financial statements are included in its Annual Report 2024 that was published on February 21, more information about Philips' AGM 2025, please click on this link. For further information, please contact: Michael FuchsPhilips Global External RelationsTel.: +31 614869261E-mail: media@ Dorin DanuPhilips Investor RelationsTel.: +31 20 59 77055E-mail: About Royal PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at Attachments Philips AGM 2025 Chairman Feike Sijbesma and a member of the Board of Management Marnix van Ginneken during Philips AGM 2025
